ArticleJournal of Alzheimer's disease reports
Low premorbid IQ effects biomarker-cognition relationships: A pilot study.
Article in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Previously, we found that plasma levels of phosphorylated tau 181 (p-tau 181), total tau (T-tau), and neurofilament light (NfL) differ significantly based on premorbid intellectual ability (pIQ). Objective: This study examines how these biomarkers are associated with cognitive outcomes across pIQ and racial/ethnic groups. Methods: Participants from the Health & Aging Brain Study-Health Disparities (HABS-HD) were categorized as having low (z ≤ -2.00) or average (z = 0.00 ± 1.00) pIQ using word reading scores. Regression analyses were conducted. Results: Among participants with low pIQ, elevated plasma p-tau 181 was more strongly associated with worse episodic memory. In stratified analyses, NfL, p-tau 181, and t-tau were differentially and inconsistently associated with cognitive outcomes, with varying strength based on pIQ grouping. Conclusions: A one-size-fits-all approach to biomarker-cognition associations interpretation may overlook important individual differences driven by pIQ. These exploratory analyses provide preliminary evidence to support future studies aimed at validating cognitive stratification in biomarker interpretation and interventions for individuals with low pIQ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.